Interestingly, it was observed that, in the total NSCLC group, an increased level of SFRP5 was present in tumour samples obtained from stage III NSCLC patients compared to stage I. In the literature, the SFRP5 protein concentration in cancers is still not explored enough. This evidence concerns the gene SFRP5 and neoplasm.